Driving Digital in Biopharma

An exploration of the digital trends and technology driving change in the biopharmaceutical industry. In-depth conversations with industry leaders at the forefront of transformation.

Innovating Oncology Patient Experience with Data, Digital & Tech 03/07/2024

Innovating Oncology Patient Experience with Data, Digital & Tech In this episode of the Driving Digital in Biopharma podcast, Samer Ansari, Head of Data, Digital, and Technology at Takeda Oncology, joins Tom Lehmann, Global Head of Accenture Life Sciences R&D, to discuss the role of digital in creating exceptional HCP and patient experiences. Through their shared passion for data and tech and the importance of using it to positively change not only the Life Sciences industry but also the lives of our loved ones, Samer and Tom explore how Takeda is leveraging data to create a meaningful impact on patients’ experiences. We glimpse into the actions Samer and his team are taking around the globe, discuss how their organizational structure and innovation mindset create the opportunity for agility, and explore real-life applications of technology to improve patient outcomes. Samer emphasizes the need to balance investment choices with business expectations and ultimately showcase the impact of those investments, while always keeping the patient at heart. /episode/index/show/biopharma/id/30254328

A modern balancing act: Harmonizing digital, data and traditional ways of working 11/03/2023

A modern balancing act: Harmonizing digital, data and traditional ways of working In this episode of Driving Digital in Biopharma, Accenture host, Tom Lehmann, speaks to Chris Braithwaite, Global Head of Drug Development, Digital and IT Novartis. Achieving digital transformation requires a delicate balance between traditional methods, rapidly emerging technology, and human decision-making. Chris encourages a shift in perspective and a focus on change management, emphasizing that working in a human+machine mode does not entail eliminating human roles. Instead, it involves developing comfort and knowledge regarding data and technology to enhance human potential and increase role effectiveness. By embracing digital tools and leveraging data, organizations can empower themselves to make informed decisions, drive adoption, and ultimately improve patient care. /episode/index/show/biopharma/id/28507175

Design for the future and deliver progress over perfection 04/27/2023

Design for the future and deliver progress over perfection In this episode of Driving Digital in Biopharma, Accenture host, Tom Lehmann, talks with Michel Rider, VP Digital, Analytics and Performance at GSK. Michel reflects on their multi-year quest to modernize digital, data, and analytics capabilities across Development – sharing insights for achieving near-term wins while planning for the future. There is a sense of urgency for patients seeking better, faster treatments. And this is a non-linear endeavor – iteration and evolution are a given. A compressed transformation approach combined with agile experimentation can deliver tangible benefits quickly and establish a foundation for future growth. /episode/index/show/biopharma/id/26637306

Rethink it: Digital is not a thing, digital is a means 02/28/2023

Rethink it: Digital is not a thing, digital is a means In this episode of Driving Digital in Biopharma, host Tom Lehmann talks with Jason Bronfeld, Head of Product Development IT at Bristol-Myers Squibb, about the industry re-perceiving itself and capitalizing on the power of digital. When it comes to evolving ways of operating to an ever-better model for the future, a mindset shift is essential – digital is a means and not the end. The biopharma industry is viewed as knowledge-generating enterprises, and while ever-growing amounts of data present complex challenges, a strong digital core will fuel competitive advantages. /episode/index/show/biopharma/id/26082453

2022 Life Sciences Tech Trends - The Metaverse Continuum for Supply Chain 11/29/2022

2022 Life Sciences Tech Trends - The Metaverse Continuum for Supply Chain In this episode, Tom Lehmann talks with Natasha Kelly, a data scientist within Accenture's Applied Intelligence Group who focuses on advanced analytic solutions in life sciences manufacturing and supply chain. Tom and Natasha discuss the 2022 Life Sciences Technology Vision through a supply chain lens, delving into how each of the report's four trends ingrained in the metaverse are reshaping supply chain and operations experiences across the industry. /episode/index/show/biopharma/id/25130754

2022 Life Sciences Tech Trends - The Metaverse Continuum for Biopharma R&D 11/11/2022

2022 Life Sciences Tech Trends - The Metaverse Continuum for Biopharma R&D In this episode, Tom Lehmann talks with Accenture’s Ross Wooddisse, Managing Director and Life Sciences R&D Lead in Europe, about the 2022 Life Sciences Technology Vision and what the Metaverse continuum means for Biopharma R&D. They discuss how science turns into medicine, a new generation of digital trial capabilities and the fundamental opportunity for the industry to move from disease management towards risk prediction and disease prevention. /episode/index/show/biopharma/id/24981459

2022 Life Sciences Tech Trends Overview 09/12/2022

2022 Life Sciences Tech Trends Overview In this episode Tom Lehmann talks with Shalu Chada, Managing Director and Accenture’s Life Sciences Technology Lead, to discuss the 2022 Life Sciences Technology Vision and how each of the report's four trends ingrained in the metaverse are reshaping biopharma experiences of the future. /episode/index/show/biopharma/id/24313635

Enabling tomorrow's science through digital 08/24/2022

Enabling tomorrow's science through digital In this episode of Driving Digital in Biopharma, host Tom Lehmann talks with Anders Persson – Executive Director, Ecosystem Strategy & Innovation, AstraZeneca, about the role of digital and data in the transformation of global drug development and the value of an ecosystem and partnership strategy in R&D. /episode/index/show/biopharma/id/24133866

From documents to data - Regulatory's future? 07/12/2022

From documents to data - Regulatory's future? Tom Lehmann and Eddie Reilly, Chief regulatory officer and head of global regulatory affairs, Sanofi discuss delivering new therapies to patients more efficiently and how that’s enabled by regulatory affairs - from standardizing data and harnessing AI to the more proficiently exchanging data with health authorities. /episode/index/show/biopharma/id/23719901

Raising the innovation bar in early research and development 05/25/2022

Raising the innovation bar in early research and development Host Tom Lehmann talks with Lars Fogh Iversen, Senior Vice Present for Digital Science & Innovation at Novo Nordisk. They discuss the journey to accelerate research and early development through laboratory automation, data management, AI and digital research. /episode/index/show/biopharma/id/23166767

Enabling scientific curiosity through digital in drug discovery 04/05/2022

Enabling scientific curiosity through digital in drug discovery In Episode 11, host Tom Lehmann and guest Julie Huxley-Jones, GSK, discuss the mindset of scientific curiosity, innovation and collaboration and its role on the impact of digital in scientific discovery. They talk about the unique journey of digital in discovery research and how it’s increasing productivity and innovation. /episode/index/show/biopharma/id/22624994

Digital health and unlocking the value of data 02/24/2022

Digital health and unlocking the value of data Savyon Amit talks with Tom Lehmann about AstraZeneca's aligned understanding of Digital Health and the importance of articulating the value of digital from an organizational standpoint as well as value to the broader healthcare ecosystem. /episode/index/show/biopharma/id/22232972

How a human health care philosophy is shaping a digital transformation 01/12/2022

How a human health care philosophy is shaping a digital transformation Tom Lehmann talks with Stephen Davies, VP, Eisai Enterprise Information Technology about Eisai’s human health care philosophy. It’s guiding innovation, shaping digital transformation and encouraging a holistic health care view by leveraging technology beyond traditional therapeutics. /episode/index/show/biopharma/id/21756371

Data is the new currency for drug development 11/17/2021

Data is the new currency for drug development In this episode Venkat Sethuraman, SVP Global Biometrics and Data Science, Bristol-Myers Squibb talks with Tom Lehmann about the critical role of data, design and digital in the future vision for R&D. /episode/index/show/biopharma/id/21198281

Decentralized methods and the future of clinical research 10/07/2021

Decentralized methods and the future of clinical research Host Tom Lehmann talks with Craig Lipset, a long-time advocate and inspiring innovator in the clinical research and medicine development community. Drawing on his role as co-convenor of the Decentralized Trials and Research Alliance (DTRA), a collaboration of over 120 member organizations, Craig discusses DTRA’s ambitions and priorities for bringing greater accessibility to clinical trials and making decentralized clinical research methods the standard for the industry. /episode/index/show/biopharma/id/20676776

Life Sciences Tech Trends 2021: From Me to We 09/23/2021

Life Sciences Tech Trends 2021: From Me to We Tom Lehmann talks with Frances Taheri, Accenture Ventures Digital Health Lead, about the need for companies to enable their ecosystems to collaborate freely without compromising data security and privacy in the conclusion of our Life Sciences Tech Trends series. /episode/index/show/biopharma/id/20489435

Life Sciences Tech Trends 2021: Anywhere, Everywhere 09/23/2021

Life Sciences Tech Trends 2021: Anywhere, Everywhere Tom Lehmann talks again with David Hole about the “bring your own environment” (BYOE) model that will drive the industry’s technology agenda in terms of connectivity, collaboration and the tools that enable them in part four of our Life Sciences Tech Trends series. /episode/index/show/biopharma/id/20489372

Life Sciences Tech Trends 2021: I, Technologist 09/23/2021

Life Sciences Tech Trends 2021: I, Technologist Tom Lehmann talks with David Hole, Accenture Life Sciences Talent and Organization Lead, about making technology accessible to all to put powerful capabilities in the hands of people across functions in part three of our Life Sciences Tech Trends series. /episode/index/show/biopharma/id/20489297

Life Sciences Tech Trends 2021: Mirrored World 09/23/2021

Life Sciences Tech Trends 2021: Mirrored World Tom Lehmann talks with Andy Greenberg, Accenture North America Digital Health Lead, about the therapeutic potential of massive, intelligent, digital twins in part two of our Life Sciences Tech Trends series. /episode/index/show/biopharma/id/20514545

Life Sciences Tech Trends 2021: Stack Strategically 09/23/2021

Life Sciences Tech Trends 2021: Stack Strategically Host Tom Lehmann begins this special series centered on the 2021 Life Sciences Technology Vision with Shalu Chadha, Accenture Life Sciences Technology Lead, about architecting a better future with technology stacks that are fluid across the ecosystem. /episode/index/show/biopharma/id/20489219

In search of the digital thread 07/16/2021

In search of the digital thread Host Tom Lehmann talks with John Kelleher, head of digital quality for Pfizer global supply. John shares insights on connecting learnings and impacts of a digital QA transformation pilot to a more holistic QC transformation initiative. /episode/index/show/biopharma/id/19835042

The 4 P's of digital transformation 05/07/2021

The 4 P's of digital transformation Debraj Dasgupta talks with Tom Lehmann about the building blocks and historic obstacles to a successful digital transformation in biopharma. /episode/index/show/biopharma/id/19022552

Digital’s positive role in patient health 03/24/2021

Digital’s positive role in patient health Tom Lehmann discusses tapping into digital to achieve greater patient-centricity with Jen Spada and Tina Ripperger. /episode/index/show/biopharma/id/18442559

Digital is greater than technology 02/19/2021

Digital is greater than technology Tom Lehmann discusses digital strategy and transformation wins with Guido Radack, Vice President, Strategic Initiatives Leader at Bayer. /episode/index/show/biopharma/id/18015674

Digital at the Pace of Science 01/05/2021

Digital at the Pace of Science Host Tom Lehmann talks with Kailash Swarna, global head of R&D digitalization strategy at NovoNordisk about data complexity, measuring digital value, keeping pace with the next generation of science and patient centricity. /episode/index/show/biopharma/id/17437139

An Industry at a Crossroad: Digitalization in Biopharma R&D 06/10/2020

An Industry at a Crossroad: Digitalization in Biopharma R&D

In this premier episode of our new podcast series, host Tom Lehmann explores findings from our report on Digitalization in Biopharma R&D with one of the co-authors, Katie Miinch. Together, they unpack key insights and what the findings mean for companies today and into the future.

/episode/index/show/biopharma/id/16031744

Driving Digital in Biopharma

TOPICS